期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 57, 期 21, 页码 8971-8983出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm501095r
关键词
-
资金
- 973 Program [2014CB845604]
- National Natural Science of Foundation of China [21172273, 21171177, 91122010]
- Program for Changjiang Scholars and Innovative Research Team in University of China [IRT1298]
- Research Fund for the Doctoral Program of Higher Education [20110171110013]
Recently, coordinatively saturated and substitutionally inert Ru(II) complexes have been investigated as anticancer agents. Herein a cyclometalated Ru(II) complex, [Ru(bpy)(phpy)(dppz)](+), was found to be rapidly taken up by cancer cells, and nearly 90% of the complex accumulated in the nuclei of cancer cells after a 2 h incubation. The anticancer activity of this complex was screened against a panel of cancer cell lines. Remarkably, it exhibited IC50 values that were an order of magnitude lower than those of cisplatin. This complex also displayed potencies superior to those of cisplatin against 3D tumor spheroids. Further studies revealed that the high DNA binding affinity of [Ru(bpy)(phpy)(dppz)](+) resulted in effective disruption of the binding of transcription factor NF-kappa B to DNA sequences, thereby inhibiting cellular transcription and leading to irreversible cancer cell apoptosis. Our work provides new insights into understanding the biological interactions and anticancer molecular mechanisms of DNA-specific Ru(II) polypyridyl complexes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据